Skip to content

Implementation of a Depression Screening Intervention at a Transgender Health Clinic in Thailand

Implementation of a Depression Screening Intervention at a Transgender Health Clinic in Thailand

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05323695
Acronym
CHIMERA
Enrollment
317
Registered
2022-04-12
Start date
2021-10-11
Completion date
2024-07-02
Last updated
2024-11-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Symptoms

Keywords

Depression, Transgender women

Brief summary

The study aims to develop and implement a depression screening intervention into routine HIV and sexual health service provision at a transgender health clinic in Thailand, and to explore the facilitators, barriers, feasibility and acceptability of the screening implementation.

Detailed description

The study will follow a mixed-methods approach that will incorporate quantitative and qualitative components. Aim 1 will involve the development and implementation of depression screening intervention at Tangerine Clinic. Aim 2 will involve semi-structured interviews with a purposive subset of participants who received the intervention and healthcare providers to explore the multilevel facilitators, barriers, feasibility and acceptability of the screening implementation. Aim 3 will evaluate the proportion of participants who are offered, accept, and receive the peer-led depression screening intervention, and the proportion who screen positive.

Interventions

BEHAVIORALDepression Screening Intervention

All participants will be screened for depression using PHQ-2 and PHQ-9. Those screened positive for PHQ-2 but decline further screening with PHQ-9 will be assisted for further assessment or care. Those with mild to severe symptoms (score of 7 or higher on PHQ-9) will be assisted for further assessment or care with a psychiatrist.

Sponsors

amfAR, The Foundation for AIDS Research
CollaboratorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
Fogarty International Center of the National Institute of Health
CollaboratorNIH
Thai Red Cross AIDS Research Centre
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Thai nationality 2. Transgender women ≥18 years 3. Attending the Tangerine Clinic for routine care visits during the intervention period. 4. Can be a new or returning clients.

Exclusion criteria

1\. Transgender women currently receiving care for a mental health diagnosis will be excluded from participating in this study. Inclusion Criteria for healthcare providers: 1. Currently working at the Tangerine Clinic 2. Can be medical doctors, nurses, peer counselors and other members of the clinic management team involved in the routine delivery of HIV and health services to Transgender women.

Design outcomes

Primary

MeasureTime frameDescription
Intervention Acceptability: Number of participants who accepted interventionDay 1Acceptability will be measured by the number of clients who were offered and accepted the intervention.
Intervention Acceptability: Participants' perspective of the intervention through in-depth interviewsDay 1Acceptability will be assessed qualitatively through post-intervention in-depth interviews.
Intervention Acceptability: Participants' perspective of the intervention through focus group discussionDay 1Acceptability will be assessed qualitatively through post-intervention focus group discussion.
Intervention Feasibility: Number of intervention completedDay 1Feasibility will be measured by number of intervention completed. Point estimates of \>50% of participants completed is considered as the minimum criteria for feasibility.
Intervention Feasibility: Participants' perspective of the intervention through in-depth interviewsDay 1Feasibility will be assessed qualitatively through post-intervention in-depth interviews.
Intervention Feasibility: Participants' perspective of the intervention through focus group discussion.Day 1Feasibility will be assessed qualitatively through post-intervention focus group discussion.
Number of participants screening positive for depressionDay 1Screening positive is defined as scoring 7 or greater on PHQ-9. The total possible score for PHQ-9 is 27, with 0-6 being minimum and indicating no depressive symptoms, 7-12 mild depression, 13-18 moderate depression, and 19-27 severe depression.

Countries

Thailand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026